Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Conduct a value analysis of cash back cards with no fees to make smart financial choices. Understand the benefits and options available.
25,276 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Anthropic, the Claude-maker, confidentially files to go public, igniting talk of a potential trillion-dollar valuatio...
The tech world is buzzing as Nvidia moves beyond GPUs and into CPU territory. This shift could reshape who wins and w...
As SpaceX edges toward a trillion-dollar valuation, wealth managers confront a new scale of risk. A single misstep ca...
Bitcoin fans have watched a calm stretch emerge around the $60,000 mark. This article breaks down what that steady vi...
A growing strategy lets corporate executives push $100K+ into a single-year 401K by leveraging the 415(C) rule and af...
Jim Cramer argues Meta's AI model shift delivered a roughly $100 per share move, illustrating why big tech remains ha...
After a dramatic fall, Bitcoin traders expect more pain ahead as BTC slips from its peak. This guide breaks down what...
Analysts lift HIMS, TDOC, and ALEC as strategic partnerships reduce key risks, prompting renewed upside potential and...
MSFO continues to pay weekly distributions despite a sharp stock slide in Microsoft. As MSFT falls, MSFO investors we...
Nebius Group delivered a blowout Q1 2026, with revenue growth of 684% and a high-stakes push from NVIDIA and Meta, tr...
A leading hedge fund shocks markets with a major pivot into AI infrastructure, prioritizing hardware, energy-ready da...